Maria Chondrogianni

  • Citations Per Year
Learn More
Multifocal angiopathy associated with cannabis consumption is an uncommon cause of ischemic stroke in young individuals. The main radiological characteristics include the presence of multifocal intracranial stenosis and the reversibility of vasoconstriction after cannabis withdrawal. Cannabis use has been linked recently to other arterial complications,(More)
The differential diagnosis of dementia with Lewy bodies (DLB) and sporadic Creutzfeldt-Jakob disease (CJD) may be challenging. Patients with the original diagnosis of possible CJD may occasionally prove to have a pathological diagnosis of DLB, while other cases may fulfill the diagnostic clinical criteria for DLB but subsequent clinical course,(More)
The current definition of paroxysmal atrial fibrillation (PAF) requires an arbitrary cut-off of >30s, but in clinical practice cryptogenic stroke (CS) patients with PAF duration of ≤30s are not usually excluded from anticoagulation therapy. We sought to evaluate the clinical relevance of short-duration (≤30s) PAF in CS. Consecutive CS patients with no prior(More)
BACKGROUND Novel oral anticoagulants (NOACs) have shown to be both safe and effective for ischemic stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). We conducted a network meta-analysis (NMA) using published data from secondary prevention subgroups of different phase III randomized clinical trials (RCTs) comparing individual NOACs(More)
Maurizio Paciaroni, MD; Giancarlo Agnelli, MD; Valeria Caso, MD, PhD; Georgios Tsivgoulis, MD; Karen L. Furie, MD; Prasanna Tadi, MD; Cecilia Becattini, MD; Nicola Falocci, PhD; Marialuisa Zedde, MD; Azmil H. Abdul-Rahim, MD; Kennedy R. Lees, MD; Andrea Alberti, MD; Michele Venti, MD, PhD; Monica Acciarresi, MD; Cataldo D’Amore, MD; Maria Giulia Mosconi,(More)
BACKGROUND AND PURPOSE Plasma GFAP (glial fibrillary acidic protein) has recently emerged as a potential biomarker for the differentiation of acute intracerebral hemorrhage (ICH) from acute ischemic stroke (AIS). We prospectively assessed the diagnostic accuracy of GFAP in the differential diagnosis of ICH. METHODS Consecutive patients presenting to the(More)
BACKGROUND We sought to evaluate the potential enhanced fibrinolytic and antiplatelet activity of dabigatran etexilate (DE) due to decreased thrombin levels in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation (NVAF). METHODS Consecutive patients with cerebrovascular diseases and NVAF that were treated with DE in a(More)